Mereo BioPharma Group Ownership 2024 | Who Owns Mereo BioPharma Group Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

0.00%

Insider Ownership

0.55%

Retail Ownership

99.45%

Institutional Holders

37.00

Mereo BioPharma Group Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RUBRIC CAPITAL MANAGEMENT LP0.00%1.32%13,552,997--44,724,890Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.06%9,328,7396,678,739252.03%30,784,839Mar 31, 2024
MANGROVE PARTNERS0.00%2.01%8,752,893--28,884,547Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.00%0.68%8,142,109158,2581.98%26,868,960Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC0.00%1.39%5,750,000-450,000-7.26%18,975,000Mar 31, 2024
JANUS HENDERSON GROUP PLC0.00%0.01%5,120,5735,120,573100.00%16,949,097Mar 31, 2024
ALKEON CAPITAL MANAGEMENT LLC0.00%0.02%4,238,100--13,985,730Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC0.00%0.45%3,653,494-3,717,344-50.43%12,056,530Mar 31, 2024
CLEARLINE CAPITAL LP0.00%0.54%3,326,718--10,978,170Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.00%0.64%2,616,953-7,160,466-73.23%8,635,945Mar 31, 2024
TEJARA CAPITAL LTD0.00%3.00%2,470,184-1,242,945-33.47%8,151,607Mar 31, 2024
GOLDMAN SACHS GROUP INC0.00%0.00%2,243,814220,14210.88%7,404,586Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.00%0.00%2,179,135768,81854.51%7,191,145Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.00%0.01%1,672,309-125,700-6.99%5,519,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.00%0.00%1,619,6271,619,627100.00%5,344,769Mar 31, 2024
MORGAN STANLEY0.00%0.00%1,382,6891,306,5241715.39%4,562,874Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.00%0.00%991,971991,971100.00%3,274,000Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.00%0.29%950,000950,000100.00%3,135,000Mar 31, 2024
ABRDN PLC0.00%0.01%817,309-733,773-47.31%2,697,120Mar 31, 2024
NEOS INVESTMENT MANAGEMENT LLC0.00%0.13%623,430271,52577.16%2,057,319Mar 31, 2024

Mereo BioPharma Group's largest institutional shareholder is RUBRIC CAPITAL MANAGEMENT LP, holding 0.00% of the company's total share outstanding, currently valued at $44.72M. The top 10 institutional shareholders own together 0.01% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TEJARA CAPITAL LTD0.00%3.00%2,470,184-1,242,945-33.47%8,151,607Mar 31, 2024
MANGROVE PARTNERS0.00%2.01%8,752,893--28,884,547Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC0.00%1.39%5,750,000-450,000-7.26%18,975,000Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP0.00%1.32%13,552,997--44,724,890Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC0.00%0.85%397,884397,884100.00%1,313,017Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.00%0.68%8,142,109158,2581.98%26,868,960Mar 31, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.00%0.64%2,616,953-7,160,466-73.23%8,635,945Mar 31, 2024
CLEARLINE CAPITAL LP0.00%0.54%3,326,718--10,978,170Mar 31, 2024
KNOLL CAPITAL MANAGEMENT, LLC-0.53%260,470100,00062.32%859,551Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC0.00%0.45%3,653,494-3,717,344-50.43%12,056,530Mar 31, 2024
MONACO ASSET MANAGEMENT SAM0.00%0.40%405,000-271,494-40.13%1,336,500Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.00%0.29%950,000950,000100.00%3,135,000Mar 31, 2024
ARTIA GLOBAL PARTNERS LP0.00%0.28%421,359421,359100.00%1,390,485Mar 31, 2024
EAM GLOBAL INVESTORS LLC-0.15%195,087195,087100.00%643,787Mar 31, 2024
NEOS INVESTMENT MANAGEMENT LLC0.00%0.13%623,430271,52577.16%2,057,319Mar 31, 2024
FOREFRONT ANALYTICS, LLC-0.07%43,8177,69321.30%144,598Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.06%9,328,7396,678,739252.03%30,784,839Mar 31, 2024
KNOTT DAVID M JR-0.04%30,00030,000100.00%99,000Mar 31, 2024
J. GOLDMAN & CO LP-0.03%278,588116,58871.97%919,340Mar 31, 2024
ALKEON CAPITAL MANAGEMENT LLC0.00%0.02%4,238,100--13,985,730Mar 31, 2024

The largest Mereo BioPharma Group shareholder by % of total assets is TEJARA CAPITAL LTD. The company owns 2.47M shares of Mereo BioPharma Group (MREO), representing 3.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.06%9,328,7396,678,739252.03%30,784,839Mar 31, 2024
JANUS HENDERSON GROUP PLC0.00%0.01%5,120,5735,120,573100.00%16,949,097Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.00%0.00%1,619,6271,619,627100.00%5,344,769Mar 31, 2024
MORGAN STANLEY0.00%0.00%1,382,6891,306,5241715.39%4,562,874Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.00%0.00%991,971991,971100.00%3,274,000Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.00%0.29%950,000950,000100.00%3,135,000Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.00%0.00%2,179,135768,81854.51%7,191,145Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.00%0.01%485,436485,436100.00%1,601,939Mar 31, 2024
ARTIA GLOBAL PARTNERS LP0.00%0.28%421,359421,359100.00%1,390,485Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC0.00%0.85%397,884397,884100.00%1,313,017Mar 31, 2024
NEOS INVESTMENT MANAGEMENT LLC0.00%0.13%623,430271,52577.16%2,057,319Mar 31, 2024
GOLDMAN SACHS GROUP INC0.00%0.00%2,243,814220,14210.88%7,404,586Mar 31, 2024
EAM GLOBAL INVESTORS LLC-0.15%195,087195,087100.00%643,787Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP-0.00%164,800164,800100.00%543,840Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.00%0.68%8,142,109158,2581.98%26,868,960Mar 31, 2024
TD ASSET MANAGEMENT INC-0.00%148,000148,000100.00%488,400Mar 31, 2024
JUMP FINANCIAL, LLC-0.01%126,500126,500100.00%417,450Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP-0.00%119,100119,100100.00%393,030Mar 31, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE-0.00%118,978118,978100.00%392,627Mar 31, 2024
J. GOLDMAN & CO LP-0.03%278,588116,58871.97%919,340Mar 31, 2024

As of Mar 31 2024, Mereo BioPharma Group's largest institutional buyer is ADAGE CAPITAL PARTNERS GP, L.L.C.. The company purchased 6.68M stocks of MREO, valued at $30.78M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SOLEUS CAPITAL MANAGEMENT, L.P.0.00%0.64%2,616,953-7,160,466-73.23%8,635,945Mar 31, 2024
SUVRETTA CAPITAL MANAGEMENT, LLC0.00%0.45%3,653,494-3,717,344-50.43%12,056,530Mar 31, 2024
TEJARA CAPITAL LTD0.00%3.00%2,470,184-1,242,945-33.47%8,151,607Mar 31, 2024
DAFNA CAPITAL MANAGEMENT LLC----778,813-100.00%-Mar 31, 2024
ABRDN PLC0.00%0.01%817,309-733,773-47.31%2,697,120Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC0.00%1.39%5,750,000-450,000-7.26%18,975,000Mar 31, 2024
TOROSO INVESTMENTS, LLC----319,390-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC--43,907-280,912-86.48%144,893Mar 31, 2024
MONACO ASSET MANAGEMENT SAM0.00%0.40%405,000-271,494-40.13%1,336,500Mar 31, 2024
SQUAREPOINT OPS LLC----257,700-100.00%-Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.00%0.01%1,672,309-125,700-6.99%5,519,000Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----62,843-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----50,100-100.00%-Mar 31, 2024
HSBC HOLDINGS PLC-0.00%28,577-29,640-50.91%94,304Mar 31, 2024
LYNWOOD CAPITAL MANAGEMENT INC.----25,000-100.00%-Mar 31, 2024
MARSHALL WACE, LLP----14,883-100.00%-Mar 31, 2024
SCIENTECH RESEARCH LLC----13,955-100.00%-Mar 31, 2024
CLEAR HARBOR ASSET MANAGEMENT, LLC-0.01%46,000-13,754-23.02%151,800Mar 31, 2024
UBS GROUP AG----2,813-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----1,800-100.00%-Mar 31, 2024

As of Mar 31 2024, Mereo BioPharma Group's biggest institutional seller is SOLEUS CAPITAL MANAGEMENT, L.P.. The company sold -7.16M shares of MREO, valued at $8.64M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
JANUS HENDERSON GROUP PLC0.00%0.01%5,120,5735,120,573100.00%16,949,097Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.00%0.00%1,619,6271,619,627100.00%5,344,769Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.00%0.00%991,971991,971100.00%3,274,000Mar 31, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC0.00%0.29%950,000950,000100.00%3,135,000Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.00%0.01%485,436485,436100.00%1,601,939Mar 31, 2024
ARTIA GLOBAL PARTNERS LP0.00%0.28%421,359421,359100.00%1,390,485Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC0.00%0.85%397,884397,884100.00%1,313,017Mar 31, 2024
EAM GLOBAL INVESTORS LLC-0.15%195,087195,087100.00%643,787Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP-0.00%164,800164,800100.00%543,840Mar 31, 2024
TD ASSET MANAGEMENT INC-0.00%148,000148,000100.00%488,400Mar 31, 2024
JUMP FINANCIAL, LLC-0.01%126,500126,500100.00%417,450Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP-0.00%119,100119,100100.00%393,030Mar 31, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE-0.00%118,978118,978100.00%392,627Mar 31, 2024
GSA CAPITAL PARTNERS LLP-0.02%75,78775,787100.00%250,000Mar 31, 2024
SQUAREPOINT OPS LLC-0.00%47,68747,687100.00%157,367Mar 31, 2024
GTS SECURITIES LLC-0.00%30,10030,100100.00%99,330Mar 31, 2024
INDEX FUND ADVISORS, INC.-0.01%30,00030,000100.00%99,000Mar 31, 2024
KNOTT DAVID M JR-0.04%30,00030,000100.00%99,000Mar 31, 2024
SIMPLEX TRADING, LLC-0.00%29,24229,242100.00%96,000Mar 31, 2024
TUDOR INVESTMENT CORP ET AL-0.00%26,17926,179100.00%86,391Mar 31, 2024
SG AMERICAS SECURITIES, LLC-0.00%16,22116,221100.00%54,000Mar 31, 2024
GTS SECURITIES LLC-0.00%15,66415,664100.00%51,691Mar 31, 2024
TOTAL CLARITY WEALTH MANAGEMENT, INC.-0.01%11,86011,860100.00%39,138Mar 31, 2024
GTS SECURITIES LLC-0.00%11,70011,700100.00%38,610Mar 31, 2024
ADVISORS PREFERRED, LLC-0.00%8,2628,262100.00%28,173Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%7,1457,145100.00%23,578Mar 31, 2024
LINDBROOK CAPITAL, LLC-0.00%2,3002,300100.00%7,590Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.--1,9001,900100.00%6,270Mar 31, 2024
BFSG, LLC-0.00%1,0001,000100.00%3,300,000Mar 31, 2024
ICA GROUP WEALTH MANAGEMENT, LLC-0.00%1,0001,000100.00%3,300Mar 31, 2024
SIGNATUREFD, LLC-0.00%820820100.00%2,706,000Mar 31, 2024
QUADRANT CAPITAL GROUP LLC-0.00%739739100.00%2,439Mar 31, 2024

Mereo BioPharma Group's largest new institutional shareholder by number of shares is JANUS HENDERSON GROUP PLC, purchased 5.12M shares, valued at $16.95M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DAFNA CAPITAL MANAGEMENT LLC----778,813-100.00%-Mar 31, 2024
TOROSO INVESTMENTS, LLC----319,390-100.00%-Mar 31, 2024
SQUAREPOINT OPS LLC----257,700-100.00%-Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC----62,843-100.00%-Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC----50,100-100.00%-Mar 31, 2024
LYNWOOD CAPITAL MANAGEMENT INC.----25,000-100.00%-Mar 31, 2024
MARSHALL WACE, LLP----14,883-100.00%-Mar 31, 2024
SCIENTECH RESEARCH LLC----13,955-100.00%-Mar 31, 2024
UBS GROUP AG----2,813-100.00%-Mar 31, 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----1,800-100.00%-Mar 31, 2024
SPIRE WEALTH MANAGEMENT----250-100.00%-Mar 31, 2024

Mereo BioPharma Group's largest sold out institutional shareholder by shares sold is DAFNA CAPITAL MANAGEMENT LLC, sold -0.78M shares, valued at -, as of undefined.

Mereo BioPharma Group Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Tema ETF Trust11.69%521,779206,49865.50%Feb 29, 2024
TEKLA HEALTHCARE INVESTORS0.94%1,063,799--Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.85%487,283--Dec 31, 2023
BRIDGEWAY FUNDS INC0.01%15,961--Dec 29, 2023
PRIMECAP Odyssey Funds0.00%10,000--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%96,630--Feb 29, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%82,50325,74445.36%Feb 29, 2024
PROSHARES TRUST0.00%9,833--Feb 29, 2024
iSHARES TRUST0.00%613,897--Feb 29, 2024
John Hancock Funds II0.00%28,20028,200-Feb 29, 2024
NORTHERN FUNDS0.00%1,007--Dec 29, 2023

Mereo BioPharma Group's largest mutual fund holder by % of total assets is "Tema ETF Trust", owning 521.78K shares, compromising 11.69% of its total assets.

Mereo BioPharma Group Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2437-42.19%
31 Dec, 236418.52%
30 Sep, 23541.89%
30 Jun, 2353-7.02%
31 Mar, 2357-5.00%
31 Dec, 22603.45%
30 Sep, 2258-4.92%
30 Jun, 226110.91%
31 Mar, 2255-20.29%
31 Dec, 216915.00%
30 Sep, 2160-13.04%
30 Jun, 21691.47%
31 Mar, 216847.83%
31 Dec, 2046100.00%
30 Sep, 20239.52%
30 Jun, 2021133.33%
31 Mar, 209-18.18%
31 Dec, 1911-21.43%
30 Sep, 1914-12.50%
30 Jun, 1916-

As of 31 Mar 24, 37 institutions are holding Mereo BioPharma Group's shares, representing a decrease of -42.19% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2419,716,646-74.84%
31 Dec, 2378,368,11811.28%
30 Sep, 2370,423,9878.85%
30 Jun, 2364,699,9096.47%
31 Mar, 2360,770,987-1.29%
31 Dec, 2261,563,584-9.39%
30 Sep, 2267,944,713-8.40%
30 Jun, 2274,174,547-17.26%
31 Mar, 2289,652,670-1.99%
31 Dec, 2191,472,5873.68%
30 Sep, 2188,224,783-2.52%
30 Jun, 2190,508,590-0.91%
31 Mar, 2191,344,28756.72%
31 Dec, 2058,284,395276.71%
30 Sep, 2015,471,837112.65%
30 Jun, 207,275,733121.78%
31 Mar, 203,280,637163.64%
31 Dec, 191,244,380-30.19%
30 Sep, 191,782,499-1.00%
30 Jun, 191,800,467-

Mereo BioPharma Group (MREO) has 19.72M shares outstanding as of 31 Mar 24, down -74.84% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.00%-
31 Dec, 2364.96%1.91%
30 Sep, 2358.38%2.03%
30 Jun, 2353.63%2.11%
31 Mar, 2350.37%1.93%
31 Dec, 2251.03%1.61%
30 Sep, 2256.32%1.14%
30 Jun, 2270.27%0.97%
31 Mar, 2284.93%1.13%
31 Dec, 2186.65%1.24%
30 Sep, 2183.57%0.47%
30 Jun, 21133.51%0.74%
31 Mar, 21134.74%1.82%
31 Dec, 2085.98%16.51%
30 Sep, 2022.82%19.81%
30 Jun, 2010.73%45.83%
31 Mar, 204.84%143.63%
31 Dec, 191.84%26.55%
30 Sep, 192.63%37.28%
30 Jun, 192.66%-

As of 31 Mar 24, Mereo BioPharma Group is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 2423-37.84%
31 Dec, 233794.74%
30 Sep, 231918.75%
30 Jun, 2316-27.27%
31 Mar, 2322-8.33%
31 Dec, 2224-7.69%
30 Sep, 2226-13.33%
30 Jun, 223025.00%
31 Mar, 2224-35.14%
31 Dec, 213768.18%
30 Sep, 2122-35.29%
30 Jun, 2134-26.09%
31 Mar, 214631.43%
31 Dec, 2035150.00%
30 Sep, 2014-12.50%
30 Jun, 2016300.00%
31 Mar, 204100.00%
31 Dec, 192-66.67%
30 Sep, 196-62.50%
30 Jun, 1916-

23 institutional shareholders have increased their position in MREO stock as of 31 Mar 24 compared to 37 in the previous quarter (a -37.84% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 245-54.55%
31 Dec, 2311-31.25%
30 Sep, 2316-15.79%
30 Jun, 231958.33%
31 Mar, 23129.09%
31 Dec, 2211-26.67%
30 Sep, 2215-11.76%
30 Jun, 221770.00%
31 Mar, 2210-23.08%
31 Dec, 2113-27.78%
30 Sep, 21185.88%
30 Jun, 2117142.86%
31 Mar, 21716.67%
31 Dec, 20650.00%
30 Sep, 20433.33%
30 Jun, 203-
31 Mar, 203-40.00%
31 Dec, 19566.67%
30 Sep, 193-
30 Jun, 19--

5 institutional shareholders have reduced their position in MREO stock as of 31 Mar 24 compared to 11 in the previous quarter (a -54.55% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2437-42.19%19,716,646-74.84%0.00%-23-37.84%5-54.55%
31 Dec, 236418.52%78,368,11811.28%64.96%1.91%3794.74%11-31.25%
30 Sep, 23541.89%70,423,9878.85%58.38%2.03%1918.75%16-15.79%
30 Jun, 2353-7.02%64,699,9096.47%53.63%2.11%16-27.27%1958.33%
31 Mar, 2357-5.00%60,770,987-1.29%50.37%1.93%22-8.33%129.09%
31 Dec, 22603.45%61,563,584-9.39%51.03%1.61%24-7.69%11-26.67%
30 Sep, 2258-4.92%67,944,713-8.40%56.32%1.14%26-13.33%15-11.76%
30 Jun, 226110.91%74,174,547-17.26%70.27%0.97%3025.00%1770.00%
31 Mar, 2255-20.29%89,652,670-1.99%84.93%1.13%24-35.14%10-23.08%
31 Dec, 216915.00%91,472,5873.68%86.65%1.24%3768.18%13-27.78%
30 Sep, 2160-13.04%88,224,783-2.52%83.57%0.47%22-35.29%185.88%
30 Jun, 21691.47%90,508,590-0.91%133.51%0.74%34-26.09%17142.86%
31 Mar, 216847.83%91,344,28756.72%134.74%1.82%4631.43%716.67%
31 Dec, 2046100.00%58,284,395276.71%85.98%16.51%35150.00%650.00%
30 Sep, 20239.52%15,471,837112.65%22.82%19.81%14-12.50%433.33%
30 Jun, 2021133.33%7,275,733121.78%10.73%45.83%16300.00%3-
31 Mar, 209-18.18%3,280,637163.64%4.84%143.63%4100.00%3-40.00%
31 Dec, 1911-21.43%1,244,380-30.19%1.84%26.55%2-66.67%566.67%
30 Sep, 1914-12.50%1,782,499-1.00%2.63%37.28%6-62.50%3-
30 Jun, 1916-1,800,467-2.66%-16---

Mereo BioPharma Group Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Feb 09, 2024Ekblom Andersdirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Ekblom Andersdirector-A-AwardBuy19,471--19,471
Feb 09, 2024Jacquet Pierredirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Jacquet Pierredirector-A-AwardBuy15,553--15,553
Feb 09, 2024Yoskowitz Marc Jdirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Yoskowitz Marc Jdirector-A-AwardBuy14,139--14,139
Feb 09, 2024PAKIANATHAN DEEPIKAdirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024WYZGA MICHAEL Sdirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024WYZGA MICHAEL Sdirector-A-AwardBuy30,783--30,783
Feb 09, 2024Shames Danieldirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Shames Danieldirector-A-AwardBuy14,139--14,139
Feb 09, 2024Jenkins Annalisadirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Jenkins Annalisadirector-A-AwardBuy14,947--14,947
Feb 09, 2024Bender Jeremydirector-A-AwardBuy45,000$3.87$174.15K45,000
Feb 09, 2024Bender Jeremydirector-A-AwardBuy16,361--16,361
Jan 26, 2024Scots-Knight Deniseofficer Chief Executive OfficerA-AwardBuy850,000$3.36$2.86M850,000
Jan 26, 2024Sermon Charlesofficer General CounselA-AwardBuy245,000$3.36$823.20K245,000
Jan 26, 2024Hughes-Wilson Alexandraofficer See RemarksA-AwardBuy196,000$3.36$658.56K196,000
Jan 26, 2024Lewicki John A.officer Chief Scientific OfficerA-AwardBuy137,000$3.36$460.32K137,000
Jan 26, 2024Fox Christine Annofficer Chief Financial OfficerA-AwardBuy245,000$3.36$823.20K245,000

Mereo BioPharma Group Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024207725.97%

20 total buy trades, and 77 total sell trades (buy/sell ratio of 0.26%) were made by Mereo BioPharma Group's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 2024---

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Mereo BioPharma Group's stocks.

Mereo BioPharma Group Peer Ownership


TickerCompany
TERNTerns Pharmaceuticals, Inc.
ABOSAcumen Pharmaceuticals, Inc.
ELEVElevation Oncology, Inc.
XFORX4 Pharmaceuticals, Inc.
INZYInozyme Pharma, Inc.
DAWNDay One Biopharmaceuticals, Inc.
PDSBPDS Biotechnology Corporation
AMLXAmylyx Pharmaceuticals, Inc.
EFTReFFECTOR Therapeutics, Inc.
HOOKHOOKIPA Pharma Inc.
HEPAHepion Pharmaceuticals, Inc.

MREO Ownership FAQ


Mereo BioPharma Group is owned by institutional shareholders (0.00%), insiders (0.55%), and public (99.45%). The largest institutional shareholder of Mereo BioPharma Group is RUBRIC CAPITAL MANAGEMENT LP (0.00% of total shares) and the top mutual fund owner is Tema ETF Trust (11.69% of total shares).

Mereo BioPharma Group's major institutional shareholders are RUBRIC CAPITAL MANAGEMENT LP, ADAGE CAPITAL PARTNERS GP, L.L.C., MANGROVE PARTNERS, ROCK SPRINGS CAPITAL MANAGEMENT LP, and 683 CAPITAL MANAGEMENT, LLC. The top five shareholders own together 0.01% of the company's share outstanding.

As of Mar 2024, there are 37 institutional shareholders of Mereo BioPharma Group.

RUBRIC CAPITAL MANAGEMENT LP owns 13.55M shares of Mereo BioPharma Group, representing 0.00% of the company's total shares outstanding, valued at $44.72M (as of Mar 2024).

As of Mar 2024, ADAGE CAPITAL PARTNERS GP, L.L.C holds 9.33M shares of Mereo BioPharma Group (MREO), compromising 0.00% of the company, valued at $30.78M.

MANGROVE PARTNERS is the third largest holder of Mereo BioPharma Group. The company owns 8.75M of the company's shares outstanding (worth $28.88M).